Francois Godard

Dijon, 21000, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Tackling data scarcity: Synthetic tumour and mask generation to improve image segmentation.

Tackling data scarcity: Synthetic tumour and mask generation to improve image segmentation.

Journal: Artificial intelligence in medicine
Published: August 01, 2025

Estimation of carbon footprint in nuclear medicine: illustration of a french department.

Estimation of carbon footprint in nuclear medicine: illustration of a french department.

Journal: European journal of nuclear medicine and molecular imaging
Published: October 07, 2024

Incidental Detection of Brain Metastases From a Pulmonary Large Cell Neuroendocrine Carcinoma at 18 F-Fluorocholine PET/CT in a Context of Primary Hyperparathyroidism.

Incidental Detection of Brain Metastases From a Pulmonary Large Cell Neuroendocrine Carcinoma at 18 F-Fluorocholine PET/CT in a Context of Primary Hyperparathyroidism.

Journal: Clinical nuclear medicine
Published: September 26, 2024

Whole Spinal Cord FDG Uptake at PET/CT Caused by H3K27-Altered Diffuse Midline Glioma in an Adult Patient.

Whole Spinal Cord FDG Uptake at PET/CT Caused by H3K27-Altered Diffuse Midline Glioma in an Adult Patient.

Journal: Clinical nuclear medicine
Published: May 22, 2024

Pretreatment CT Texture Parameters as Predictive Biomarkers of Progression-Free Survival in Follicular Lymphoma Treated with Immunochemotherapy and Rituximab Maintenance.

Pretreatment CT Texture Parameters as Predictive Biomarkers of Progression-Free Survival in Follicular Lymphoma Treated with Immunochemotherapy and Rituximab Maintenance.

Journal: Diagnostics (Basel, Switzerland)
Published: May 03, 2023

Risk Factors of Progression in Low-tumor Burden Follicular Lymphoma Initially Managed by Watch and Wait in the Era of PET and Rituximab.

Risk Factors of Progression in Low-tumor Burden Follicular Lymphoma Initially Managed by Watch and Wait in the Era of PET and Rituximab.

Journal: HemaSphere
Published: October 04, 2022

Dramatic Efficacy of Interferon and Vemurafenib on Psychiatric Symptoms Revealing BRAFV600E -Mutated Erdheim-Chester Disease: A Case Report.

Dramatic Efficacy of Interferon and Vemurafenib on Psychiatric Symptoms Revealing BRAFV600E -Mutated Erdheim-Chester Disease: A Case Report.

Journal: Frontiers in immunology
Published: May 11, 2022

Superiority of NaF PET/CT Over Chest CT in a Case of Osteosarcoma.

Superiority of NaF PET/CT Over Chest CT in a Case of Osteosarcoma.

Journal: Clinical nuclear medicine
Published: March 30, 2021

18F-FDG cerebellum/liver index as a prognostic factor for progression-free survival in diffuse large B-cell lymphoma.

18F-FDG cerebellum/liver index as a prognostic factor for progression-free survival in diffuse large B-cell lymphoma.

Journal: Annals of nuclear medicine
Published: January 09, 2021

Cerebellum/liver index in pretherapeutic 18F-FDG PET/CT as a predictive marker of progression-free survival in follicular lymphoma treated by immunochemotherapy and rituximab maintenance.

Cerebellum/liver index in pretherapeutic 18F-FDG PET/CT as a predictive marker of progression-free survival in follicular lymphoma treated by immunochemotherapy and rituximab maintenance.

Journal: Medicine
Published: August 11, 2020

Temporal Uptake Patterns of 18F-Fluorocholine Among Hyperfunctioning Parathyroid Glands.

Temporal Uptake Patterns of 18F-Fluorocholine Among Hyperfunctioning Parathyroid Glands.

Journal: Clinical nuclear medicine
Published: May 16, 2018

18F-FDG PET/CT in Anti-NMDA Receptor Encephalitis: Typical Pattern and Follow-up.

18F-FDG PET/CT in Anti-NMDA Receptor Encephalitis: Typical Pattern and Follow-up.

Journal: Clinical nuclear medicine
Published: May 10, 2018
Showing 1-12 of 12

Last Updated: 09/26/2026